119. Neutralizing Antibodies for Viruses
Saturday, October 22, 2011: 10:15 AM-11:45 AM
Room: 253ABC

Learning Objectives:

At the conclusion of this session, participants will be able to review current and emerging monoclonal antibodies for prevention and treatment of viral infections, and the mechanisms by which antibodies neutralize viruses.

Target Audience: Vaccinologists, Scientists, Researchers, Pharmacists, Microbiologists, Lab Personnel, Investigators, Infectious Diseases Physicians, Infectious Diseases Pediatricians, Infection Preventionists, HIV Clinicians, Fellows-in-Training, Academicians

Tracks: Investigative ID, HIV, Pediatric ID, Adult ID

Moderator:  James E. Crowe Jr., MD, FIDSA, Vanderbilt University

CME Credits: Maximum of 1.5 hours of Category 1 credit possible

ACPE Credits: ACPE 1.5 knowledge-based contact hours (0.15 CEU) of Pharmacy CE

ACPE Number: 0461-9999-11-152-L01-P


J. E. Crowe Jr., None

D. R. Burton, None

P. C. Wilson, MedImmune: Collaborator and Licensed antibodies we developed against influenza, Licensing agreement or royalty

E. Harris, None

See more of: Symposium

Findings in the abstracts are embargoed until 12:01 a.m. EST Thursday, Oct. 20 with the exception of research findings presented at IDSA press conferences.